---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-019127"
form_type: "8-K"
ticker: null
cik: "0001840748"
company_name: "LAVA Therapeutics NV"
filed_at: "2025-02-28T23:59:59+00:00"
generated_at: "2026-05-26T00:02:05.414631+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LAVA Therapeutics receives Nasdaq deficiency notice; shares below $1.00 for 30 days

## Summary
- Nasdaq notified LAVA on Feb 27, 2025, that its common shares failed to meet the $1.00 minimum bid price for 30 consecutive business days.
- Company has 180 days, until Aug 26, 2025, to regain compliance by closing at $1.00+ for 10 consecutive trading days.
- Failure could lead to transfer to Nasdaq Capital Market for an additional 180-day cure period if eligibility criteria are met.
- LAVA will monitor bid price and consider available options; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001104659-25-019127
- form_type: 8-K
- cik: 0001840748
- company_name: LAVA Therapeutics NV
- filed_at: 2025-02-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840748/000110465925019127/0001104659-25-019127-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840748/000110465925019127/tm257957d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-019127
- JSON: https://secwatch.observer/filing/0001104659-25-019127.json
- Plain text: https://secwatch.observer/filing/0001104659-25-019127.txt

## Key facts
- Listing & Compliance Notices
  LAVA Therapeutics NV received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: February 27, 2025, LAVA Therapeutics N.V. (the “Company”) received a notice from The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq’s Listing Rule 5450(a)(1), as the minimum bid price of the Company’s common shares has been below $1.00 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common shares on The Nasdaq Global Select Market. The Company has 180 calendar days, or until August 26, 2025, to regain compliance with the minimum bid price requirement. To regain com
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840748/000110465925019127/0001104659-25-019127-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.